

Everything you need to know about Crexont XR: what it treats, how to take it, available strengths, dosage guidelines, and important safety info.
Crexont XR is a brand-name prescription medication that contains Carbidopa and Levodopa in extended-release capsules. It is made by Amneal Pharmaceuticals and was approved by the FDA on August 7, 2024.
Crexont XR is used to treat movement problems caused by Parkinson's disease. It belongs to a class of drugs called dopaminergic antiparkinsonism agents.
Crexont XR is FDA-approved for:
To learn how the medication works in your brain, see our mechanism of action guide.
What makes Crexont XR unique is its dual-bead formulation. Each capsule contains two types of beads:
This combination is designed to give you fast symptom relief that lasts longer between doses, reducing the "wearing off" that many Parkinson's patients experience with immediate-release Carbidopa/Levodopa (like Sinemet).
Crexont XR comes in 8 strengths (Carbidopa/Levodopa):
Your doctor will choose the right strength based on your current treatment and how well your symptoms are controlled.
Follow your doctor's instructions carefully. Here are the general guidelines:
Crexont XR is not right for everyone. You should not take it if you:
Common side effects include nausea, dizziness, headache, insomnia, dry mouth, and dyskinesia (involuntary movements). Serious side effects can include hallucinations, impulse control disorders, and sudden sleepiness. For a detailed breakdown, read our Crexont XR side effects guide.
Without insurance, Crexont XR costs approximately $540–$665 for a 30-day supply (120 capsules). There is no generic version available as of February 2026.
Amneal offers a Crexont Savings Program where eligible commercially insured patients may pay as little as $25 per fill. Uninsured patients may qualify for the Amneal Patient Support Services Program. Learn more in our Crexont XR savings guide.
Because Crexont XR is a new brand-name medication, it may not be available at all pharmacies. Use MedFinder to check which pharmacies near you have it in stock. If your pharmacy doesn't carry it, they can usually order it within a few business days.
For more about availability challenges, see why Crexont XR can be hard to find and the latest shortage update for 2026.
Crexont XR is a newer extended-release Carbidopa/Levodopa medication designed for Parkinson's disease patients who want faster onset and longer-lasting symptom control. It comes in multiple strengths, can be taken as capsules or sprinkled on food, and is available through savings programs to help manage the cost. Talk to your doctor — or find a prescriber near you — to see if Crexont XR is right for you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.